Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG00012 in relapsing-remitting multiple sclerosis
ACTRN12607000124437Phase 3Recruiting
- Sponsor
- Biogen
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dimethyl fumarate, sponsored by Biogen. Started Dec 2006; status: recruiting.
02
Drugs
dimethyl fumarate
Beyond the preview
Go deeper on ACTRN12607000124437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000124437.